What happened Shares of BioNTech (NASDAQ: BNTX) jumped 10.9% this week as of the market close on Thursday. There were a couple of primary reasons behind the big gain. BioNTech's partner, Pfizer (NYSE: PFE), increased its full-year sales guidance for the companies' COVID-19 vaccine to $33.
Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting